Kyto Biopharma Inc., a biopharmaceutical company, is engaged in acquiring and developing minimally toxic and non-immunosuppressive proprietary drugs for the treatment of cancer, arthritis, and other proliferate and autoimmune diseases. History The company was founded as a Florida corporation in 1999. It was formerly known as B Twelve, Inc. and changed its name to Kyto Biopharma, Inc. in 2002.
kyto biopharma inc (KBPH:OTC US)
B1-114 Belmont Street
Toronto, ON M5R 1P8
|No competitor information is available for KBPH.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact KYTO BIOPHARMA INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.